← All reports

Ireland's access to innovative medicines has worsened compared to EU peers.

HealthcarePoliticsMay 20, 2026score 0.173 posts · 0 replies across 1 instances
The thread discusses Ireland's declining access to innovative medicines compared to EU peers, highlighting rising wait times for rare diseases despite new agreements and increased investment. This issue reflects broader challenges in healthcare policy and resource allocation within the EU.

Claims

Ireland's access to innovative medicines has worsened compared to EU peers.
Parent: HealthcareEntity: IrelandImpact: negativeDate: May 20, 2026Target: Ireland's access to innovative medicines

Source posts

@[email protected]
Ireland falls further behind EU peers on innovative medicines access [Advocacy Lab]: Rare disease wait times rise to 801 days despite new framework agreements and record investment https://www.euractiv.com/news/ireland-falls-further-behind-eu-peers-on-innovative-medicines-access/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv_economy%40eupolicy.social
0 boosts · 0 favs · 0 replies · May 20, 2026
@[email protected]
Ireland falls further behind EU peers on innovative medicines access [Advocacy Lab] https://www.euractiv.com/news/ireland-falls-further-behind-eu-peers-on-innovative-medicines-access/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv_politics%40eupolicy.social
0 boosts · 0 favs · 0 replies · May 20, 2026
@[email protected]
Ireland falls further behind EU peers on innovative medicines access [Advocacy Lab] https://www.euractiv.com/news/ireland-falls-further-behind-eu-peers-on-innovative-medicines-access/?utm_source=eac&utm_medium=mastodon&utm_campaign=%40euractiv%40masto.ai
0 boosts · 0 favs · 0 replies · May 20, 2026